Standard BioTools Inc. (LAB) vs Profound Medical (PROF)
- Standard BioTools Inc. LAB 0.63 −4.55%
- Profound Medical PROF 6.01 −4.75%
Standard BioTools Inc. and Profound Medical are both Medical Devices companies. Standard BioTools Inc. is the larger, with a market value of $258.5M against $230.5M — 1.1× the size. Profound Medical has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 2.9×. Profound Medical grew revenue faster over the last twelve months: 61.2% against 30.2%. Standard BioTools Inc. has the higher net margin (100.4% vs −171.6%) and the higher return on invested capital (−93.9% vs −137.8%). Across the 18 metrics below, Standard BioTools Inc. leads on 13 and Profound Medical on 5.
Valuation
Profitability
| Metric | LAB | PROF | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.49% | 71.79% | 56.01% |
| Operating margin | (112.85%) | (185.31%) | (15.03%) |
| Net margin | 100.37% | (171.56%) | (20.40%) |
| Free cash flow margin | (97.61%) | (189.15%) | (7.24%) |
| Return on equity | 17.61% | (73.53%) | (15.32%) |
| Return on assets | 14.34% | (58.44%) | (19.72%) |
| Return on invested capital | (93.89%) | (137.78%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack